Ad
related to: merck vaccines in development
Search results
FDA approves Moderna's RSV vaccine for seniors, the company's second-ever product
CNBC· 5 hours agoThe Food and Drug Administration on Friday approved Moderna's vaccine for respiratory syncytial...
Merck to Acquire EyeBio
Morningstar· 2 days ago“We continue to execute on our science-led business development strategy to expand and diversify our pipeline,” said Dr. Dean Y. Li, president, Merck Research ...
Merck Reaches $1.3 Billion Deal for Eye-Drug Company EyeBio
The Wall Street Journal· 2 days agoThe drug, which recently completed midstage testing, is in development for Wet AMD, as well as...
Merck is spending $3 billion on an eye drug developer as it braces to lose a key cancer patent
Quartz· 2 days ago“We continue to execute on our science-led business development strategy to expand and diversify our...
Merck eyes purchase of ophthalmology company
WFMZ Eastern Pennsylvania and Western New Jersey· 2 days agoTake Merck, for example. Its blockbuster cancer drug, Keytruda, is now the largest selling drug in the world. In the past few weeks, studies have shown...
Merck introduces sterility testing solution for pharma quality control
Pharmaceutical Technology via Yahoo Finance· 2 days agoDigital innovations like M-Trace® bring us one step closer to making the lab of the future a...
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 6 days agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
Merck Announces Third-Quarter 2024 Dividend
Morningstar· 3 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.77 per share of ...
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Zacks via Yahoo Finance· 3 days agoModerna and Merck are evaluating mRNA-4157 in two pivotal late-stage studies for melanoma and...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 2 days agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment,...
